Skip to main content

Table 3 CMM risks in patients with the specific cardiometabolic disease according to the consumption of three types of beverages in UK Biobank at 2021 (N = 37,994)

From: Associations between consumption of three types of beverages and risk of cardiometabolic multimorbidity in UK Biobank participants: a prospective cohort study

 

Numbers

Cases

HR (95% CI)

Sugar-sweetened beverages

 Hypertension

0/day

22,356

3262

1 (ref)

0–1/day

8801

1336

1.04 (0.97–1.11)

>1/day

2333

426

1.22 (1.10–1.36)

 CVD

0/day

1625

499

1 (ref)

>0/day

785

233

0.98 (0.83–1.15)

 Diabetes

0/day

1534

473

1 (ref)

>0/day

560

170

0.94 (0.78–1.13)

Artificially sweetened beverages

 Hypertension

0/day

26,134

3931

1 (ref)

0–1/day

5413

774

0.96 (0.89–1.04)

>1/day

1943

319

1.08 (0.96–1.22)

 CVD

0/day

1970

599

1 (ref)

>0/day

440

133

1.03 (0.85–1.25)

 Diabetes

0/day

1397

422

1 (ref)

>0/day

697

221

1.09 (0.92–1.29)

Pure fruit/vegetable juices

 Hypertension

0/day

15,991

2509

1 (ref)

0–1/day

15,054

2146

0.91 (0.86–0.97)

>1/day

2445

369

0.92 (0.82–1.03)

 CVD

0/day

1181

396

1 (ref)

>0/day

1229

336

0.79 (0.68–0.92)

 Diabetes

0/day

1242

378

1 (ref)

>0/day

852

265

1.00 (0.85–1.17)

  1. Adjusted for age, sex, ethnicity, deprivation index, smoking status, alcohol consumption, physical activity, sedentary time, body mass index, total sugar intake, energy intake, fat intake, vegetable and fruit intake, fish intake, red meat intake, insulin use (diabetes only), antihypertensive drug use (hypertension only), lipid-lowering drug use, and aspirin use
  2. CMM cardiometabolic multimorbidity, HR hazard ratio, CI confidence interval, CVD cardiovascular disease, ref reference